The bacterial capsule is a very large structure of many bacteria. It is a polysaccharide layer that lies outside the cell envelope, and is thus deemed part of the outer envelope of a bacterial cell. It is a well-organized layer, not easily washed off, and it can be the cause of various diseases.
The capsule—which can be found in both gram negative and gram-positive bacteria—is different to the second lipid membrane – bacterial outer membrane, which contains lipopolysaccharides and lipoproteins and is found only in gram-negative bacteria. When the amorphous viscid secretion (that makes up the capsule) diffuses into the surrounding medium and remains as a loose undemarcated secretion, it is known as slime layer. Capsule and slime layer are sometimes summarized under the term glycocalyx.
It usually consists of polysaccharides, but can be composed of other materials such as glycoprotein, polypeptide D-glutamic acid in B. anthracis, and peptidoglycan and muramic acid found in E.coli bacterial capsule. Because most capsules are so tightly packed, they are difficult to stain because most standard stains cannot adhere to the capsule. For examination under the microscope, the bacteria and their background are stained darker than the capsule, which doesn't stain. When viewed, bacterial cells as well as the surface they are on, are stained dark, while the capsule remains pale or colorless and appears as a ring, or halo, around the cell.
The capsule is considered a virulence factor because it enhances the ability of bacteria to cause disease (e.g. prevents phagocytosis). The capsule can protect cells from engulfment by eukaryotic cells, such as macrophages. A capsule-specific antibody may be required for phagocytosis to occur. Capsules also contain water which protects the bacteria against desiccation. They also exclude bacterial viruses and most hydrophobic toxic materials such as detergents. Immunity to one capsule type does not result in immunity to the other types. Capsules also help cells adhere to surfaces. As a group where the capsule is present they are known as polysaccharide encapsulated bacteria or encapsulated bacteria.
The capsule is found most commonly among gram-negative bacteria:
- Escherichia coli (in some strains)
- Neisseria meningitidis
- Klebsiella pneumoniae
- Haemophilus influenzae
- Pseudomonas aeruginosa
However, some gram-positive bacteria may also have a capsule:
- Bacillus megaterium for example, synthesizes a capsule composed of polypeptide and polysaccharides.
- Streptococcus pyogenes synthesizes a hyaluronic acid capsule.
- Streptococcus pneumoniae has at least 91 different capsular serotypes. These serotypes are the basis for the pneumococcal vaccines.
- Streptococcus agalactiae produces a polysaccharide capsule of nine antigenic types that all contain sialic acid (Ia, Ib, II, III, IV, V, VI, VII, VIII).
- Staphylococcus epidermidis
- Staphylococcus aureus
Demonstration of capsuleEdit
- India ink staining: the capsule appears as a clear halo around the bacterium as the ink can't penetrate the capsule.:87
- Maneval's capsule stain: the capsule appears as a clear halo between the pink-stained bacterium and the bluish-grey stained background. The background stain is the acidic stain Congo red (which changes color to bluish-grey due to the pH), and the pink stain is acid fuschin.
- Serological methods: Capsular material is antigenic and can be demonstrated by mixing it with a specific anticapsular serum. When examined under the microscope, the capsule appears 'swollen' due to an increase in its refractivity. This phenomenon is the basis of Quellung reaction.
Use in vaccinationEdit
Vaccination using capsular material is effective against some organisms (e.g., H. influenzae type b, S. pneumoniae, and N. meningitidis). However, polysaccharides are not highly antigenic, especially in children, so many capsular vaccines contain polysaccharides conjugated with protein carriers, such as the tetanus toxoid or diphtheria toxoid. This stimulates a much more robust immune response.
- Peterson JW (1996). "Bacterial Pathogenesis". Medical Microbiology. University of Texas Medical Branch at Galveston. Retrieved 17 January 2018.
- "bacterial capsule" at Dorland's Medical Dictionary
- Encyclopædia Britannica [Capsules and Slime Layers].
- Daffé M, Etienne G (1999). "The capsule of Mycobacterium tuberculosis and its implications for pathogenicity". Tubercle and Lung Disease. 79 (3): 153–69. doi:10.1054/tuld.1998.0200. PMID 10656114.
- Lindberg, AA (November 1999). "Polyosides (encapsulated bacteria)". Comptes Rendus de l'Académie des Sciences, Série III. 322 (11): 925–32. PMID 10646085.
- "Meningococcal meningitis". Textbookofbacteriology.net. Archived from the original on 2014-02-09. Retrieved 2014-01-22.
- Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S, Yamaguchi K (November 2000). "Role of bacterial capsule in local and systemic inflammatory responses of mice during pulmonary infection with Klebsiella pneumoniae". Journal of Medical Microbiology. 49 (11): 1003–10. doi:10.1099/0022-1317-49-11-1003. PMID 11073154.
- Schouls L, van der Heide H, Witteveen S, Zomer B, van der Ende A, Burger M, Schot C (February 2008). "Two variants among Haemophilus influenzae serotype b strains with distinct bcs4, hcsA and hcsB genes display differences in expression of the polysaccharide capsule". BMC Microbiology. 8 (1): 35. doi:10.1186/1471-2180-8-35. PMC 2267795. PMID 18298818.
- Deretic V, Dikshit R, Konyecsni WM, Chakrabarty AM, Misra TK (March 1989). "The algR gene, which regulates mucoidy in Pseudomonas aeruginosa, belongs to a class of environmentally responsive genes". Journal of Bacteriology. 171 (3): 1278–83. PMC 209741. PMID 2493441.
- Gibson DL, White AP, Snyder SD, Martin S, Heiss C, Azadi P, Surette M, Kay WW (November 2006). "Salmonella produces an O-antigen capsule regulated by AgfD and important for environmental persistence". Journal of Bacteriology. 188 (22): 7722–30. doi:10.1128/JB.00809-06. PMC 1636306. PMID 17079680.
- Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS (February 2010). "The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms". Infection and Immunity. 78 (2): 704–15. doi:10.1128/IAI.00881-09. PMC 2812187. PMID 19948837.
- Gates MA, Thorkildson P, Kozel TR (April 2004). "Molecular architecture of the Cryptococcus neoformans capsule". Molecular Microbiology. 52 (1): 13–24. doi:10.1111/j.1365-2958.2003.03957.x. PMID 15049807.
- Rudolph K (1996). "Chapter 3: Pseudomonas synringae pathovars". In Singh RP, Kohmoto K, Singh US. Pathogenesis & Host Specificity in Plant Diseases. Volume 1: Prokaryotes (1st ed.). Amsterdam: Elsevier Science. ISBN 978-0-08-098473-5.
- Goldblatt D (January 2000). "Conjugate vaccines". Clinical and Experimental Immunology. 119 (1): 1–3. doi:10.1046/j.1365-2249.2000.01109.x. PMC 1905528. PMID 10671089.